Broadspire® Enhances Comprehensive Assessment and Management of Pain (CAMP) Program

By GlobeNewswire,  August 19, 2014, 01:00:00 PM EDT


Broadspire® Enhances Comprehensive Assessment and Management of Pain (CAMP) Program

Program combines provider education with structured monitoring and peer review to

identify and address the needs of individuals in pain

ATLANTA (August 19, 2014) - Broadspire® has enhanced its innovative Comprehensive Assessment and Management of Pain (CAMP) Program to address the needs of injured and disabled workers and their employers by adding an opioid tapering component this month as well as the first opioid fill program in September 2014. First introduced at this year's national RIMS Conference, the CAMP program uses evidence-based medicine along with an integrated systemic approach to identify and address the needs of individuals in pain. Broadspire is a leading global third-party administrator of workers compensation claims, liability claims and medical management services.

"CAMP is built on evidence-based medical research with a documented a set of proven methods and tools that have been structured into a comprehensive, systematic, integrated and cost-effective approach to yield optimal outcomes for employees and employers," said Dr. Jacob Lazarovic, MD, FAAFP, senior vice president and chief medical officer, Broadspire.  "The overarching philosophy of this program is that pain is a biopsychosocial condition, and that failure to adequately address all these components will often result in unfavorable results."

There is broad recognition in the medical management industry that chronic pain is one of the central issues in workers compensation that must be managed in order to successfully contain medical and indemnity expenses, and to maximize the comfort, functionality, quality of life, and return-to-work capacity of injured workers.

The massive scope of managing pain in patients is based on the size of the affected population and estimated treatment costs, including:



  • Studies indicate that the median prevalence of chronic pain in our population is 15%.
  • The economic burden of pain, combining medical costs and lost productivity, is estimated at $600 billion annually.
  • Prescription costs may constitute up to 19% of total medical expenses, and opioids represent 30% of these costs.
  • The "opioid epidemic" has resulted in up to a nine-fold increase in morbidity and mortality, with little evidence that opioid pain medications may confer long-term benefit despite the escalation of opioid dosages over the years.
  • Physician dispensing of medications has emerged as a trend which further exacerbates the problem, creating unfavorable incentives for prolonged analgesic use and disability.



The objectives of the CAMP Program are:



  • Early identification of high-risk individuals, which incorporate a new "first opioid fill" component. Within two weeks of initiation of opioids, contact is made with the treating physician and patient, and systematic education and intervention are triggered.
  • Timely evaluation and intervention to prevent and/or impact chronicity.
  • Effective use of internal and external resources, ensuring coordinated selection, application and management of the appropriate expertise.
  • Establishment and measurement of program outcomes using metrics related to clinical quality, medical costs, and return-to-work. A brochure on the program may be downloaded here: http://www.choosebroadspire.com/media/11765/bsi-camprimsonesheet-04-17-14-mp.pdf.
  • CAMP components include: narcotic intervention; specimen drug monitoring; cognitive behavioral therapy; opioid tapering and addiction therapy; functional restoration / interdisciplinary pain management; and pharmacogenomic testing. The program integrates seamlessly with all of Broadspire's medical management resources and specialty partners.

     About Broadspire®

    Broadspire (www.choosebroadspire.com), a global third party administrator, offers casualty claim, medical management, disability and absence management solutions, and risk management information services, helping increase employee productivity and reducing the cost of risk through early intervention, professional expertise and data analytics. As a Crawford Company, Broadspire is based in Atlanta; Ga. Services are offered by Crawford & Company under the Broadspire brand in countries outside the U.S.

    About Crawford

    Based in Atlanta, Ga., Crawford & Company (www.crawfordandcompany.com) is the world's largest independent provider of claims management solutions to the risk management and insurance industry as well as self-insured entities, with an expansive global network serving clients in more than 70 countries. The Crawford Solution(SM) offers comprehensive, integrated claims services, business process outsourcing and consulting services for major product lines including property and casualty claims management, workers compensation claims and medical management, and legal settlement administration. The Company's shares are traded on the NYSE under the symbols CRDA and CRDB.

    # # #

    For more information, please contact:

    John L'Abate, public relations manager

    404.300.1908 (office)

    404.226.2931 (cell)

    jwlaba@us.crawco.com               







    This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

    Source: Crawford & Company via Globenewswire

    HUG#1849860



    This article appears in: News Headlines

    Referenced Stocks: CRDA


    Latest News Video





    Most Active by Volume

    Company Last Sale Change Net / %
    PBR $ 12.11 0.72 ▼ 5.61%
    AAPL $ 104.83 1.84 ▲ 1.79%
    BAC $ 16.60 0.20 ▲ 1.22%
    NOK $ 8.40 0.47 ▲ 5.93%
    T $ 33.66 0.84 ▼ 2.43%
    QQQ $ 97.82 1.45 ▲ 1.50%
    MSFT $ 45.02 0.64 ▲ 1.44%
    FB $ 80.04 1.67 ▲ 2.13%

    As of 10/23/2014, 04:15 PM